CCS hires Richard Field as COO, North America
Field is leading the North American operations and corporate development of CCS to ensure high
quality sales, support, and operations for CCS’s rapidly expanding client base. “We are proud to be
serving many of the leading pharmaceutical and biotechnology companies in USA and Canada,
and want to maintain the highest quality products, service and support our clients have come to
enjoy”, Richard Field is outlining his goal...
22.11.09
CCS launches subsidiary in the USA
CCS Cell Culture Service has launched a new US subsidiary in the state of California. Since 8 years, CCS is supporting pharmaceutical companies in their drug screening campaigns. "The expansion into the US market will facilitate a closer collaboration with our American customers and let.....
13.10.08
CCS has Recertified its Quality Management System
CCS Cell Culture Service's Quality Management System has been recertified according to ISO 9001:2008. During the recent years CCS has steadily expanded and improved its administrative and manufacturing procedures. After the initial certification in 2003 the quality management system has now.....
07.10.09
CCS Cell Culture Service GmbH and Cytocentrics AG agree Cooperation in the Field of Cell Line Development
Biotechnology companies CCS Cell Culture Service GmbH and Cytocentrics AG today announced the signing of a research and license agreement. The aim of the cooperation is to develop electrophysiologically optimized ion channel cell lines which allow a reliable testing of substances and drugs.....
15.09.08
New Head of Molecular Biology
Since the beginning of 2008 Dr. Anne Schlueter is managing the department of Molecular Biology of CCS Cell Culture Service. She is taking over the function of Dr. Christian Bauer who has left the company at the end of the year....
07.08.08
Innovationsstiftung Hamburg Supports Research Project of CCS
CCS Cell Culture Service is developing novel cell based assays, to analyze the selective effect of compounds on G protein-coupled receptors (GPCRs) in heterodimeric complexes. GPCRs constitute the largest family of membrane proteins and more than 50 percent of drugs on the market today target GPCRs.....
19.05.08

